Literature DB >> 7726375

CT and MR of the brain in the diagnosis of organic acidemias. Experiences from 107 patients.

J Brismar1, P T Ozand.   

Abstract

The results of CT and/or MRI of the brain in 107 patients with different types of organic acidemia are presented. The CSF spaces were wide in more than two-thirds of the patients, in 46 slightly-to-moderately and in 26 markedly-to-severely dilated. Marked widening of the operculae was found in all 5 patients with glutaric acidemia type 1, but open opercula was also found in other organic acidemias. White matter changes were found in about half the patients, in 28 mildly-to-moderately pronounced, in another 28 marked or severe. Basal ganglia or central pathway pathology was seen in a total of 34 patients, i.e. 32%. These changes in 25 patients involved the caudate and/or lentiform nuclei: in 14 cases the T2 signal was increased and volume loss was present, in 9 cases increased T2 signal with preserved volume was found (in one of these the changes were transient). In 2 patients, both with ethylmalonic aciduria (cause unknown), only small high T2 spots were seen in the caudate heads and the putamina. In 4 patients, all suffering from methylmalonic acidemia, only the globus pallidus was affected. In 3 patients, all with beta-ketothiolase deficiency, high T2 intensity changes were seen only in the postero-lateral putamina. The remaining 8 patients represent a variety of different locations of lesions. The CT or MRI findings in many patients with organic acidemias should alert the radiologist that a neurometabolic disorder may be present; in some cases the location and appearance of the lesions may even suggest the correct diagnosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7726375     DOI: 10.1016/0387-7604(94)90103-1

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  20 in total

1.  Methylmalonic acid induces excitotoxic neuronal damage in vitro.

Authors:  S Kölker; B Ahlemeyer; J Krieglstein; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

Review 2.  Glutaric aciduria type 1 and neonatal screening: time to proceed--with caution.

Authors:  Andrea Superti-Furga
Journal:  Eur J Pediatr       Date:  2003-10-25       Impact factor: 3.183

Review 3.  Magnetic resonance imaging in lactic acidosis.

Authors:  M S van der Knaap; C Jakobs; J Valk
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Methylmalonyl-CoA mutase induction by cerebral ischemia and neurotoxicity of the mitochondrial toxin methylmalonic acid.

Authors:  P Narasimhan; R Sklar; M Murrell; R A Swanson; F R Sharp
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

5.  Propionic acid induces cytoskeletal alterations in cultured astrocytes from rat cerebral cortex.

Authors:  Lúcia Maria Vieira de Almeida; Cláudia Funchal; Carmem Gottfried; Moacir Wajner; Regina Pessoa-Pureur
Journal:  Metab Brain Dis       Date:  2006-04-27       Impact factor: 3.584

6.  Diffusion-weighted MR imaging and MR spectroscopy in glutaric aciduria type 1.

Authors:  K K Oguz; A Ozturk; A Cila
Journal:  Neuroradiology       Date:  2005-03-18       Impact factor: 2.804

7.  Continuous Renal Replacement Therapy for Treatment of Severe Attacks of Inborn Errors of Metabolism.

Authors:  Ayse Filiz Yetimakman; Selman Kesici; Murat Tanyildiz; Benan Bayrakci
Journal:  J Pediatr Intensive Care       Date:  2019-03-27

8.  Diffusion-weighted imaging in the assessment of neurological damage in patients with methylmalonic aciduria.

Authors:  A P Burlina; R Manara; M Calderone; S Catuogno; A B Burlina
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

9.  Neurological outcome of methylmalonic acidaemia.

Authors:  P Nicolaides; J Leonard; R Surtees
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

10.  Ethylmalonic acid induces permeability transition in isolated brain mitochondria.

Authors:  Cristiane Cecatto; Alexandre Umpierrez Amaral; Guilhian Leipnitz; Roger Frigério Castilho; Moacir Wajner
Journal:  Neurotox Res       Date:  2014-02-21       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.